Compare Stocks → top AI stock (it’s not MSFT, GOOGL, AMZN or AAPL) (From Traders Agency) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:APOPOTCMKTS:CTTCNASDAQ:CYTXOTCMKTS:ECIANASDAQ:LENS Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPOPCellect Biotechnology$13.17+0.4%$11.51$6.64▼$35.52$12.87M1.87479,845 shs17,400 shsCTTCCalmare Therapeutics$0.00$0.00▼$0.02N/AN/A41,986 shsN/ACYTXCytori Therapeutics$1.63-3.6%$0.20$0.20▼$0.75$36.12M1.96915,302 shs24,611 shsECIAEncision$0.44+2.3%$0.54$0.25▼$0.75$5.15M0.374,494 shs11,006 shsLENSPresbia$0.15$0.23▼$5.50$258K2.57122,366 shsN/A10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPOPCellect Biotechnology0.00%0.00%0.00%0.00%0.00%CTTCCalmare Therapeutics0.00%0.00%0.00%0.00%-99.59%CYTXCytori Therapeutics0.00%-6.32%-12.83%-26.91%+517.42%ECIAEncision+1.44%-37.14%-12.00%-4.35%+12.82%LENSPresbia0.00%0.00%0.00%0.00%0.00%[Shocking] Elon Musk’s Plan To End Banks (Ad)Leaked Elon Musk call reveals shocking plan to replace banks. As Musk's plan rolls out, industry experts predict it could spark a wave of mass crypto adoption. Triggering a new crypto bull run. While helping drive a booming crypto asset class up from $2.5-billion to $16-trillion (a 6,400x increase) by 2030. Click here now to get your copy.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPOPCellect BiotechnologyN/AN/AN/AN/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/ACYTXCytori TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/AN/AN/AN/ALENSPresbiaN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPOPCellect BiotechnologyN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/ACYTXCytori TherapeuticsN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/ALENSPresbiaN/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPOPCellect BiotechnologyN/AN/AN/AN/A$4.77 per shareN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/AN/ACYTXCytori Therapeutics$3.67M9.84N/AN/A$0.35 per share4.66ECIAEncision$7.35M0.71N/AN/A$0.21 per share2.10LENSPresbia$20K0.00N/AN/A$0.09 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPOPCellect Biotechnology-$5.62MN/A0.00∞N/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/A0.00N/AN/AN/AN/AN/AN/ACYTXCytori Therapeutics-$12.63MN/A0.00∞N/A-242.60%-272.70%-56.23%N/AECIAEncision-$320K-$0.04N/A∞N/A-6.51%-18.97%-10.50%6/20/2024 (Estimated)LENSPresbia-$8.41MN/A0.00N/AN/A-36,604.35%-414.02%-195.56%N/ALatest CTTC, LENS, ECIA, APOP, and CYTX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/14/2024Q3 2024ECIAEncisionN/A-$0.02-$0.02-$0.02N/A$1.58 millionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPOPCellect BiotechnologyN/AN/AN/AN/AN/ACTTCCalmare TherapeuticsN/AN/AN/AN/AN/ACYTXCytori TherapeuticsN/AN/AN/AN/AN/AECIAEncisionN/AN/AN/AN/AN/ALENSPresbiaN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPOPCellect BiotechnologyN/A3.013.01CTTCCalmare TherapeuticsN/AN/AN/ACYTXCytori Therapeutics0.390.460.30ECIAEncision0.112.551.08LENSPresbia1.242.882.82OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPOPCellect Biotechnology4.84%CTTCCalmare TherapeuticsN/ACYTXCytori Therapeutics2.62%ECIAEncision8.20%LENSPresbia16.42%Insider OwnershipCompanyInsider OwnershipAPOPCellect BiotechnologyN/ACTTCCalmare Therapeutics17.50%CYTXCytori Therapeutics0.66%ECIAEncision40.87%LENSPresbia74.20%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableAPOPCellect Biotechnology2,020977,000N/ANot OptionableCTTCCalmare Therapeutics7N/AN/ANot OptionableCYTXCytori Therapeutics3722.16 millionN/ANot OptionableECIAEncision3111.87 million7.02 millionNot OptionableLENSPresbia2417.23 millionN/ANot OptionableCTTC, LENS, ECIA, APOP, and CYTX HeadlinesSourceHeadlineContact Lens Fitting in the Refractive Surgery Patientmedscape.com - February 23 at 11:29 PM12 Of The Best Contact Lenses, According To An Ophthalmologistforbes.com - February 7 at 12:24 AMArsenal 6-0 Lens - Highlightsbeinsports.com - February 4 at 11:59 PMContact Lens King Couponstime.com - February 1 at 9:13 PMReal and virtual imagesbbc.co.uk - January 16 at 6:32 PM10 Best Headlight Lens Cleanersrecombu.com - December 13 at 3:46 AMLens 2 Arsenal 1 - Highlightsbeinsports.com - November 20 at 7:58 PMA Town Called Victoriapbs.org - November 14 at 3:37 PM10 Best Fisheye Lenses For Nikon Camerasrecombu.com - October 29 at 10:18 AMLenses: From Fire Starters To Smart Phones And VRhackaday.com - October 9 at 1:20 PMMeta Quest 3 now has prescription VR lenses through Zenni Opticalzdnet.com - October 8 at 9:24 AMArsenal lose Bukayo Saka to injury in shock Champions League defeat as Lens come from behind to winindependent.co.uk - October 7 at 7:53 AMMagnifying Power and Focal Length of a Lenseducation.com - August 21 at 3:42 PMThe Best Fuji X Lenses for 2023uk.pcmag.com - August 17 at 6:44 PMCanon FD Lenses On An EOS Mounthackaday.com - August 16 at 4:34 AMWhat is a Micro Lens Array? The brighter telly tech explainedstuff.tv - August 13 at 11:06 PMAndre Onana has Old Trafford debut to forget as Manchester United come from behind to beat Lensindependent.co.uk - August 12 at 9:13 PMProbably The Cheapest Lens You Will Ever Usehackaday.com - August 4 at 10:19 PMA Wigglegram Lens With Variable Aperturehackaday.com - August 2 at 3:46 AMplastic lenshackaday.com - July 10 at 5:55 PMIndications and Techniques of Intraocular Lens Removalmedscape.com - July 8 at 5:54 PMTrying Out A 3D Printed Microscope Lens Adapterhackaday.com - June 23 at 8:24 PMLenses For DIY Augmented Reality Will Get A Bit Less Unobtainablehackaday.com - June 23 at 8:24 PM3D Printed Eyeglasses, VR Lenseshackaday.com - June 15 at 6:47 PMTop HeadlinesAkebia Therapeutics Surges on FDA Approval for Anemia TreatmentApril 3, 2024 9:10 AMView Akebia Therapeutics Surges on FDA Approval for Anemia TreatmentHow and When to Roll Your Options Positions? March 27, 2024 9:32 AMView How and When to Roll Your Options Positions? DexCom Stock Gains from GLP-1 Diabetic UsersApril 2, 2024 7:16 AMView DexCom Stock Gains from GLP-1 Diabetic UsersSilicon Motion Proves That AI in Motion Stays in MotionApril 16, 2024 11:42 AMView Silicon Motion Proves That AI in Motion Stays in MotionPriceSmart Could Be the Smartest Buy of the YearApril 11, 2024 7:35 AMView PriceSmart Could Be the Smartest Buy of the YearAll Headlines Company DescriptionsCellect BiotechnologyNASDAQ:APOPCellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel.Calmare TherapeuticsOTCMKTS:CTTCCalmare Therapeutics Incorporated, a medical device company, develops and commercializes products and technologies for chronic neuropathic pain and wound care affliction patients in the United States. Its flagship medical device is Calmare Pain Therapy Device, a non-invasive and non-addictive modality for the treatment of chronic and neuropathic pain. The company was formerly known as Competitive Technologies, Inc. and changed its name to Calmare Therapeutics Incorporated in August 2014. Calmare Therapeutics Incorporated was founded in 1968 and is based in Fairfield, Connecticut.Cytori TherapeuticsNASDAQ:CYTXCytori Therapeutics, Inc. is a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions. It offers the Cytori Nanomedicine, Cytori Cell Therapy, and other clinical trials. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in San Diego, CA.EncisionOTCMKTS:ECIAEncision Inc., a medical device company, designs, develops, manufactures, and markets patented surgical instruments in the United States. The company provides active electrode monitoring (AEM) surgical instruments and monitors that enhance patient safety and patient outcomes in laparoscopic surgical procedures. Its AEM instruments product line comprises a range of endo-mechanical instruments, including scissors, graspers, and dissectors, as well as fixed-tip electrodes and suction-irrigation electrodes. The company also offers various handles, which are used for advanced laparoscopic procedures that incorporate stiffer shafts and ergonomic features; and AEM EndoShield 2 burn protection systems, as well as markets AEM monitor product line that is used in conjunction with AEM instruments. The company sells its products through a network of direct and independent sales representatives. Encision Inc. was incorporated in 1991 and is based in Boulder, Colorado.PresbiaNASDAQ:LENSPresbia PLC is a holding company. It engages in the development and marketing of presbyopia-correcting solutions under the trademark of Presbia Flexivue Microlens. It operates through the Restoration of Clear Vision Caused by Presbyopia segment. The company was founded on February 2, 2014 and is headquartered in Dublin, Ireland. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.